Sanjay D. Khare

Biography

 Dr. Khare founded ImmunGene in 2008, where he has been serving as a President and CEO.  Previously, Dr. Khare spent almost 9 years at Amgen Inc with increasing responsibility to Scientific Director in the department of Inflammation/Immunology.  While at Amgen, Dr. Khare co-discovered key immune co-stimulatory molecules such as B7RP1 and B cell activating Factor (e.g. BAFF). Dr. Khare led several drug discovery programs related to immune cell costimulation and bifunctional molecules to optimize therapeutics.  Dr. Khare is co-inventor of several patents while working in Amgen and as an advisor to the start up Biotech companies.  Several of these inventions have resulted in more than US$1B potential deals from large Pharmaceutical companies. Dr. Khare coauthored more than 50 scientific papers, abstracts and edited a book on TNF superfamily.  Dr. Khare has successfully capitalized ImmunGene from Angel investors, VC fundings,  non-profit organization (LLS) and the NIH-SBIR.  Sanjay received his Ph.D. in Immunology at the All-India Institute of Medical Sciences, New Delhi, India and did his postdoctoral fellowship in the Immunology department at the Mayo Clinic and Medical School. He is a recipient of ASHI scholar award in 1997.

Research Interest

 Immunology, Molecular Biology, Drug discovery